Page last updated: 2024-11-06

floxuridine and Leukemia, Promyelocytic, Acute

floxuridine has been researched along with Leukemia, Promyelocytic, Acute in 1 studies

Floxuridine: An antineoplastic antimetabolite that is metabolized to fluorouracil when administered by rapid injection; when administered by slow, continuous, intra-arterial infusion, it is converted to floxuridine monophosphate. It has been used to treat hepatic metastases of gastrointestinal adenocarcinomas and for palliation in malignant neoplasms of the liver and gastrointestinal tract.
floxuridine : A pyrimidine 2'-deoxyribonucleoside compound having 5-fluorouracil as the nucleobase; used to treat hepatic metastases of gastrointestinal adenocarcinomas and for palliation in malignant neoplasms of the liver and gastrointestinal tract.

Leukemia, Promyelocytic, Acute: An acute myeloid leukemia in which abnormal PROMYELOCYTES predominate. It is frequently associated with DISSEMINATED INTRAVASCULAR COAGULATION.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Munch-Petersen, B1
Völker, C1
Cloos, L1
Hofbauer, R1
Mortensen, BT1
Tyrsted, G1

Other Studies

1 other study available for floxuridine and Leukemia, Promyelocytic, Acute

ArticleYear
Altered substrate and inhibitor specificity of purified human adult thymidine kinases (TK2) from leukemic cells.
    Advances in experimental medicine and biology, 1994, Volume: 370

    Topics: Adult; Cell Line; Floxuridine; Humans; Isoenzymes; Leukemia, Myeloid, Acute; Leukemia, Promyelocytic

1994